Home/Filings/4/0001213900-18-008296
4//SEC Filing

Ferrara Napoleone 4

Accession 0001213900-18-008296

CIK 0001498382other

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 7:51 PM ET

Size

7.7 KB

Accession

0001213900-18-008296

Insider Transaction Report

Form 4
Period: 2018-06-22
Transactions
  • Award

    Options (Right to Buy)

    2018-06-22+54,51454,514 total
    Exercise: $0.70Exp: 2028-06-22Common Stock (54,514 underlying)
  • Award

    Performance Stock Units

    2018-06-22+200,000200,000 total
    Exp: 2022-07-07Common Stock (200,000 underlying)
Footnotes (2)
  • [F1]One-third of the award vests on May 31, 2019, the remainder of the award vests in equal installments each three months thereafter, commencing on August 31, 2019
  • [F2]Each performance stock unit represents the right to receive one share of common stock upon vesting of the unit based on achievement of specified targets related to the Company's financial performance.

Documents

1 file

Issuer

DelMar Pharmaceuticals, Inc.

CIK 0001498382

Entity typeother

Related Parties

1
  • filerCIK 0001744779

Filing Metadata

Form type
4
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 7:51 PM ET
Size
7.7 KB